Mark B. Vieyra

Suggest Changes
  • Citations Per Year
Learn More
PURPOSE To evaluate the effect of bevacizumab, a VEGF inhibitor, on optic nerve edema and retinal ganglion cell (RGC) loss in a mouse model of optic nerve crush (ONC). METHODS Two hundred C57BL/6(More)
  • 1